PDUFA IV Is “Golden Opportunity” To Improve Drug Safety Funding And Staff

The current round of reauthorization of the Prescription Drug User Fee Act presents a "golden opportunity" to improve FDA's regulation of drug safety, according to the Institute of Medicine's Assessment of the U.S. Drug Safety System Committee